Study evaluates effectiveness and safety of TMF for chronic hepatitis B
Background and aims Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for ...
Background and aims Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for ...
Early use of AHCC during hepatitis stages shows potential to reduce the risk of cirrhosis, according to new research Study: ...
New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both ...
Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score). ...
Background and aims Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic ...
The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each ...
Background and aims The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) ...
New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis ...
In this interview, we explore global and local efforts to combat viral hepatitis with Lindsey Hiebert, Deputy Director of the ...
In a recent study published in JAMA Network Open, researchers investigated the relationship between state coronavirus disease 2019 (COVID-19) vaccination ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net